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Yersinia pestis (Yp) causes the re-emerging disease plague, and is classified by the CDC
and NIAID as a highest priority (Category A) pathogen. Currently, there is no approved
human vaccine available and advances in early diagnostics and effective therapeutics
are urgently needed. A deep understanding of the mechanisms of host response to Yp
infection can significantly advance these three areas. We employed the Reverse Phase
Protein Microarray (RPMA) technology to reveal the dynamic states of either protein level
changes or phosphorylation changes associated with kinase-driven signaling pathways
during host cell response to Yp infection. RPMA allowed quantitative profiling of changes
in the intracellular communication network of human lung epithelial cells at different
times post infection and in response to different treatment conditions, which included
infection with the virulent Yp strain CO92, infection with a derivative avirulent strain CO92
(Pgm-, Pst-), treatment with heat inactivated CO92, and treatment with LPS. Responses
to a total of 111 validated antibodies were profiled, leading to discovery of 12 novel protein
hits. The RPMA analysis also identified several protein hits previously reported in the
context of Yp infection. Furthermore, the results validated several proteins previously
reported in the context of infection with other Yersinia species or implicated for potential
relevance through recombinant protein and cell transfection studies. The RPMA results
point to strongmodulation of survival/apoptosis and cell growth pathways during early host
response and also suggest a model of negative regulation of the autophagy pathway. We
find significant cytoplasmic localization of p53 and reduced LC3-I to LC3-II conversion in
response to Yp infection, consistent with negative regulation of autophagy. These studies
allow for a deeper understanding of the pathogenesis mechanisms and the discovery of
innovative approaches for prevention, early diagnosis, and treatment of plague.
Keywords: RPMA, Yersinia pestis, host response, signaling pathways, apoptosis and autophagy, phosphorylation
changes, cell growth, proteomics
INTRODUCTION
The genus Yersinia, a member of the enterobacteriaceae family,
consists of 11 species, three of which are pathogenic to humans;
Yersinia pestis (Yp), Yersinia pseudotuberculosis, and Yersinia ente-
rocolitica. Y. pestis, the causative agent of plague, is responsible
for a number of major outbreaks throughout history and has
caused the deaths of millions of people worldwide. Today, plague
is considered a re-emerging disease, with an average of one to two
thousand cases of plague and a mortality rate of 8–10% reported
to the World Health Organization each year.
For a number of pathogenic bacteria, their ability to alter host
protein phosphorylation pathways to allow the subversion of host
defenses has been reported (Popova et al., 2010; Younossi et al.,
2011; Steiner et al., 2014). In the case of Yp, the pCD1 plasmid
encodes for bacterial virulence factors known as Yersinia Outer
Proteins (YOPs) that are used to evade the host immune response
and manipulate the host cell machinery, as well as proteins essen-
tial for the assembly of the Type Three Secretion System (TTSS)
(Cornelis, 2002b; Pujol and Bliska, 2005; Plano and Schesser,
2013). The following identified Yop effectors are important in
regulating host response, including themodulation of host signal-
ing pathways: YopE, YopH, YopJ, YopK, YopM, YopT, and YpkA
(Viboud and Bliska, 2005). Four of them, YopE, H, T, and YpkA
have been shown to alter the host cytoskeleton in order to prevent
bacterial phagocytosis (Dukuzumuremyi et al., 2000a; Cornelis,
2002b; Sauvonnet et al., 2002; Aepfelbacher et al., 2011; Ke et al.,
2013), which has been proposed to be beneficial to Yp because
it proliferates much better in the extracellular space (Rosqvist
www.frontiersin.org February 2015 | Volume 6 | Article 50 | 1
Alem et al. Host response to Yersinia pestis
et al., 1991; Cornelis, 2002a; Ke et al., 2013; Plano and Schesser,
2013). Of particular relevance to the impetus for our RPMA
study, YopH is a highly potent tyrosine phosphatase and YpkA has
serine/threonine kinase activity, and several host targets whose
phosphorylation states aremodulated by these enzymes have been
reported (Black and Bliska, 1997; Dukuzumuremyi et al., 2000b;
Navarro et al., 2007; De la Puerta et al., 2009; Rolán et al., 2013).
Yop effectors are also involved in altering other host cell signal-
ing pathways, such as the NFκB and MAPK pathways, as well as
modulating host immune responses. For example, YopJ has been
shown to interact with upstream targets of the NFκB pathway to
prevent a proinflammatory response and to initiate apoptosis in
macrophages (Orth et al., 2000).
The studies of how host pathways are altered during the course
of infection with Yp have been limited. While some host targets of
specific YOPs have been identified (Black and Bliska, 1997; Mittal
et al., 2006; De la Puerta et al., 2009) a comprehensive analysis
of how the intracellular communication mechanisms of the host
are modulated in the context of whole infection has been lack-
ing. Furthermore, an analysis of how the specific parameters of
the infection process such as the multiplicity of infection (MOI),
times post infection, or host cell type, may alter the modula-
tion of host pathways has not been yet reported. We previously
performed the first quantitative phosphoproteomic analysis of
host response to Yp infection that led to the identification of
a number of altered host signaling pathways and demonstrated
the functional relevance of the AKT pathway during Yp infec-
tion of primary human monocytes (Hakami et al., submitted for
publication). In this study, we have used the reverse phase pro-
tein microarray (RPMA) technology to perform a comparative
quantitative analysis of the modulation of host phosphorylation
under a variety of different infection parameters, including differ-
ent times post infection (p.i.), different cell types, and infection
of host cells with both a fully virulent and a derivative avir-
ulent Yp strain. In the RPMA methodology, the analytes are
robotically spotted onto nitrocellulose coated glass slides as cap-
ture molecules (hence the phrase “reverse phase”) and, after
blocking, the slides are probed with specific primary antibodies
that have been validated for single-band specificity by Western
immunoblotting and for use with RPMA. Primary antibody bind-
ing is detected using appropriate biotinylated secondary antibody
followed by streptavidin-conjugated fluorophore treatment for
detection. Eachmicroarray consists of a self-contained assay com-
prised of triplicate samples, controls and calibrators that are
analyzed with one class of antibody and amplification chem-
istry. RPMA is a novel and validated technology that has been
gaining recognition for its ability to study complex cellular sig-
naling networks through quantitative analysis of protein levels
and post translational modifications. It has been widely used in
cancer research, leading to discovery of changes in cellular sig-
naling pathways in comparative studies of normal vs. cancer cells
(Wulfkuhle et al., 2012), and more recently has also been applied
for the studies of a variety of other diseases, such as neurodegen-
erative diseases, cardiovascular disease, and infectious diseases.
The RPMA technology affords the use of a quantitative and high
throughput platform for simultaneous analysis of multiple signal-
ing pathways within the cell in order to provide an overall picture
of the signaling architecture of the cell for any given state, abilities
that are not practically afforded by the more traditional platforms
such as DOT blots or western analysis (Mueller et al., 2010).
Since an aerosol route of infection is of most concern within
the context of a biological attack, we used human lung epithe-
lial cells as one of our infection models and present the results
of our study with this cell type. In addition to validation of pub-
lished reports on host signaling in response to Yp, we report here
the identification of a number of novel proteins that show signifi-
cant change in either phosphorylation levels or total protein levels
and that have not been previously reported within the context of
Yp infection. Furthermore, since several previously reported host
response findings that we have validated here had been performed
in the context of recombinant protein expression and transfec-
tions, our results provide evidence that these host proteins are
indeed involved in the context of whole infection. We also pro-
vide a comparative profiling analysis between changes observed
during infection with the fully virulent Yp strain and a derivative
avirulent Yp strain and also changes that are observed in response
to heat-killed bacteria or LPS treatment and are therefore inde-
pendent of TTSS. Finally, based on our RPMA analysis of the
human lung epithelial cells, and also analyses of the localization of
p53 protein and LC3-I to LC3-II conversion during infection with
Yp, we propose and discuss a model of negative regulation of the
autophagy pathway as part of the host response to Yp infection in
human lung epithelial cells.
MATERIALS AND METHODS
BACTERIAL STRAINS AND REAGENTS
Bacterial strains used in this study were virulent Yersinia pestis
CO92 and a derivative avirulent strain, Yersinia pestis CO92
(Pgm-, Pst-) (a gift from Drs. Susan Welkos and Christopher
Cote, USAMRIID), that is pigmentation (pgm)-deficient and
cured of the plasminogen-activator-encoding pPst plasmid
(Welkos et al., 2002; Jenkins et al., 2009; Kota et al., 2013).
Treatment with the heat-killed version of Y. pestis CO92 strain
(heat-killed at 65◦C for 30min) was also performed. For infec-
tions, bacterial strains were streaked onto Sheep Blood Agar
(SBA) plates from a frozen stock and grown at 28◦C. A sin-
gle colony was isolated and used to inoculate cation-adjusted
Mueller-Hinton broth (CAMHB) and grown overnight at 28◦C
to use for infecting cells. Overnight cultures were enumerated
using OD600 readings (an OD600 reading of 1 is equivalent to
5.8 × 108 CFU). Antibodies used for the RPMA analysis are listed
in Supplementary Table 1, along with dilution factors used and
vendor information. All the antibodies had been previously vali-
dated for RPMA use. For each Western blot validation, and also
the LC3 Western analysis, the identical antibody used for RPMA
was utilized.
16HBE14o- CELL INFECTIONS
Immortalized human airway epithelial cells (16HBE14o-) were
purchased from Dr. D.C. Greunert (California Pacific Medical
Center Research Institute, San Francisco, CA).16HBE14o- (HBE)
cells were grown in Bronchial Epithelial Cell Basal Medium
(Clonetics™ BEGM™ BulletKit™ (CC-3170) supplemented with:
BPE, 2ml; Hydrocortisone, 0.5ml; hEGF, 0.5ml; Epinephrine,
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0.5ml; Transferrin, 0.5ml; Insulin, 0.5ml; Retinoic Acid, 0.5ml;
Triiodothyronine, 0.5ml (Lonza, Walkersville, MD). Cells were
cultured in 6 well plates and 2 × 106 cells per well were infected
at a MOI of 10 with either fully virulent strain of Y. pestis,
CO92, or a derivative avirulent Y. pestis strain CO92 (Pgm-, Pst-),
or were treated with heat-killed Y. pestis CO92. Untreated, and
E. coli lipopolysaccharide (LPS)-treated cells (100 ng/ml), were
also included as controls. Cells were harvested at 30min, 1, 4, and
8 h post infection, washed with 1× PBS and then lysed using lysis
buffer: 30ml 2× Novex Tris-Glycine SDS Sample Loading Buffer
(Invitrogen), 20ml T-PER Tissue Protein Extraction Reagent
(Thermo Scientific), 200μl 0.5M EDTA pH 8.0, 1X Complete
Protease Inhibitor Cocktail (Roche), 80μl 0.1M Na3VO4, 400μl
0.1M NaF, 1.3ml 1M DTT. Samples were then stored at −20◦C.
BACTERIAL UPTAKE AND INTRACELLULAR GROWTH MEASUREMENTS
1 × 105 16HBE14o-cells were infected with CO92 (Pgm-, Pst-)
strain at MOI of 10 and incubated at 37◦C for 2 h. The cells
were subsequently incubated with 50μg/ml gentamycin for 1 h at
37◦C to eliminate the extracellular bacteria. The cells were then
washed and resuspended in BEGM media containing 8μg/ml
Gentamycin. At designated time points post infection (0, 8, and
24 h p.i.) cells were washed and then lysed by incubating in 0.2%
Triton-× 100 for 5min at 37◦C. Dilutions of the cell lysates were
spread onto SBA plates and incubated at 37◦C to allow bacterial
colony growth. Bacterial colonies were enumerated and CFU cal-
culations were used to measure the levels of bacterial uptake and
intracellular growth.
RPMA ANALYSIS
Sample protein levels were first determined using pre-printed
slides containing all the samples as well as a BSA curve and
stained with Sypro to calculate total protein levels in the sam-
ples. Equivalent total protein amounts for samples were arrayed
onto nitrocellulose coated glass slides by direct contact print-
ing using a high resolution 2470 arrayer (Aushon Biosystems,
Brillerica, MA). RPMA analysis was performed as previously
described (Federici et al., 2013). Samples were printed in tripli-
cate and averages were calculated for analysis. Sample slides were
probed with 111 different antibodies against either total or phos-
phorylated forms of proteins that are involved in various cell
signaling pathways. A complete list of all the antibodies used for
this analysis and categorized by functional relevance is provided
in Supplementary Table 1.
RPMA DATA ANALYSIS
For each specific post-infection time point, the RPMA results
for the different infection or treatment conditions were normal-
ized to the control group (uninfected and untreated) in order
to calculate relative fold-change levels. For total protein levels, a
2-fold increase/decrease was set to be significant and for phos-
phorylation levels the significant fold increase/decrease was set
to 1.5. Proteins that showed significant fold change were then
separated into threemain categories based on the respective infec-
tion or treatment condition that elicited the observed changes
(Tables 1, 2). Extensive literature searches were performed using
Pubmed for all the proteins that showed significant fold change,
Table 1 | Categorizations of the RPMA protein hits.
Category CO92 CO92 Heat Killed LPS
(Pgm-, Pst-) CO92
1
2a
2b
3a
3b
3c
4a
4b
4c
4d
Proteins that showed a relative fold change on RPMA arrays of 1.5 and higher for
total protein levels, or 2-fold and higher for phosphorylation levels, were divided
into 4 main categories based on treatment conditions, as indicated by gray col-
ored boxes. Each category was subdivided to account for the observed changes
that occurred in response to more than one treatment condition. Category (1)
designates protein hits that were identified only in response to infection with
the virulent Y. pestis CO92 strain. Category 2 proteins designate significant
responses to either the avirulent Y. pestis CO92 (Pgm-, Pst-) strain alone (2a),
or to both the avirulent and virulent strains (2b). Category 3 proteins desig-
nate significant responses to either heat-killed Yp (HK-CO92) only (3a), or to
both HK-CO92 and the avirulent strain (3b), or to all three HK-CO92, avirulent
strain, and virulent strain treatments (3c). Category 4 proteins designate signifi-
cant responses to LPS alone (4a), or to both LPS and one or more of the other
treatment conditions, which includes LPS and Y. pestis CO92 (4b), LPS, Y. pestis
CO92, and HK-CO92 (4c), or all 4 treatments (4d).
in order to identify novel proteins that have not been previously
reported to play a role during Y. pestis-host interactions (Table 3).
WESTERN BLOT ANALYSIS
RPMA findings were validated by Western blot analysis for 6
selected proteins that displayed significant fold change on RPMA
arrays, including cleaved PARP (D214) and p53 (S15). 15 ul of
cell lysate in lysis buffer was boiled for 10min at 96◦C and
loaded onto a 4–20% bis-tris polyacrylamide gel (Invitrogen).
The gel was run at 200V for 40min, transferred to nitrocellulose
membrane using the iBlot Gel Transfer Device (Invitrogen), and
blocked overnight in 5% dry milk in PBS-T. The same primary
antibodies used for the RPMA analysis (Supplementary Table 1)
were added at appropriate dilutions in 5% dry milk/PBS-T for 1 h
at room temperature, followed by a 1 h incubation with an appro-
priate secondary antibody (goat-anti Rabbit or goat-anti Mouse)
in PBS-T. The protein bands were visualized using SuperSignal
West-Femto Maximum Sensitivity Substrate (Pierce). The blots
were imaged using Chemidoc XRS System (BioRad, CA). Actin
controls were used to normalize total protein levels for different
samples relative to one another.
LC3-B Western blots were performed as follows: 20μl of total
cell extract from uninfected/untreated cells, the cells infected with
Yp CO92, and LPS-treated cells were run on a 4–12% bis-tris
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Table 2 | Protein hits identified by RPMA and their proposed
functions in the context of Yp infection.
Protein name Time post
infection (h)
0.5 1 4 8
Possible
functional outcome
CATEGORY 1: VIRULENT Y. PESTIS STRAIN ONLY
Apoptosis
In
h
ib
it
io
n
o
f
au
to
p
h
ag
y p53 (S15) 1
S
u
rv
iv
al
Akt (S473) 1 1
Akt (T308) 1
AMPKα-1 (S485) 1
CHK-1 (S345) 1
Ras-GRF1 (S916) 1
Bad (S155) 1
CATEGORY 2: AVIRULENT Y. PESTIS STRAIN ONLY OR BOTH
AVIRULENT AND VIRULENT Y. PESTIS STRAINS
Chromatin effect Histone H3, Di-Methyl (Lys9)* 2a 2b 1
A
p
o
p
to
si
s
SAPK/JNK* 1 2b 2b
Cleaved caspase 3 (D175) 2b
Cleaved caspase 6 (D162) 2b
Cleaved caspase 7 (D198) 2a 2b
Cleaved caspase 9 (D330) 2b
Cleaved caspase 9 (D315) 2b
p53 2b 2b 2b 2b
Cleaved PARP (D214) 2a 2b
cMyc 2a
SHP2 (Y580)* 1 2b
Gab1 (Y627) 2b 2b 2b 2b
ERK 1/2 (T202/Y204) 2b 2b
PLC-γ-1 (Y783)* 1 2a
Survival p38 (T180/Y182) 2a
SHIP1 (Y1020) 2a
CATEGORIES 3 AND 4: TTSS INDEPENDENT
Immune response iNOS 3b 4c
S
u
rv
iv
al
c-Abl (T735) 4a 4b
CREB (S133) 3a 3a
Bad (S112) 3a 4d 4d 4b
Bad (S136) 3b 4b
GSK-3α (S21)* 3c 3a 1
P90RSK (S380) 4d 4b
Proteins with significant changes relative to the control condition are listed. For
each protein, the observed changes at specific post infection times are indi-
cated. Green color represents significant decrease (≥2-fold decrease for total
protein levels and ≥1.5-fold decrease for phosphorylation events) and red color
represents significant increase. Light red represents a 1.5 to 3-fold increase for
phosphorylation events and 2 to 3-fold increase for total protein levels. Medium
red represent a 3 to 6-fold increase for either phosphorylation or total protein
level changes. Dark red color, assigned only to one protein at the 1 h time point
[Histone H3, Di-Methyl (Lys 9)], represents an 11-fold increase in total level of this
protein. Category designations for each time point has been indicated based on
the categorization scheme of Table 1. The left side columns indicate possible
functional outcomes of the observed protein changes based on the known roles
of the proteins. Asterisks denote proteins that fall into different categories at
different time points.
polyacrylamide gel (Invitrogen) at 200V for 40min, and trans-
ferred to nitrocellulose membrane using the iBlot Gel Transfer
Device (Invitrogen). The membrane was blocked overnight in 5%
drymilk in PBS-T, and then washed 3 times with PBS-T and incu-
bated with the LC3B primary antibody (1:1000) for 1 h at room
temperature. Following 3 more washes with PBS-T, the secondary
antibody was added at 1:5000 dilution and the blot was incu-
bated at room temperature for 1 h. After three washes with PBS-T
to remove excess secondary antibody, the protein bands were
visualized using SuperSignal West-Femto Maximum Sensitivity
Substrate (Pierce). The blots were imaged using Chemidoc XRS
System (BioRad, CA). Actin controls were used to normalize total
protein levels for different samples relative to one another.
p53 (S15) IMMUNOFLUORESCENCE STAINING
Immunofluorescence staining was performed to analyze the cel-
lular localization of activated p53 protein (phosphorylated at
residue S15). Eight well chamber slides (EW-01838; Thermo
Scientific) were seeded with HeLa cells at a cell density of 10,000
cells per well. The following day, the cells were either left untreated
and uninfected (control), or were infected with Y. pestis CO92
(Pgm-, Pst-) at MOI of 10 for 8 h to match the exact RPMA con-
ditions that showed an effect, or were treated with Doxorubicin
as described previously (Kurz et al., 2004). Cells were then fixed
with 1% paraformaldehyde for 15min at 37◦C, and then rehy-
drated with PBS for 5min at room temperature. The cells were
subsequently permeabilized using 0.1% Triton X-100 (Sigma) for
10min at room temperature and blocked with 2% BSA (Sigma)
for 1 h at room temperature. The cells were then washed with PBS
three times and incubated with the same anti-p53 (S15) primary
antibody used in the RPMA study (Cell signaling; catalog number
9282) at 1:500 dilution for 1 h at room temperature. Subsequent
PBS washes were performed, followed by incubation with Alexa-
Fluor 488 Goat-anti Mouse secondary antibody at 1:1000 dilution
for 1 h at room temperature. The cells were then washed three
times with PBS and slides were mounted using Vectashield with
DAPI (Vector Laboratories: Burlingame, Ca). Control conditions
were also included side by side to account for any background
signal; for this, cells received an identical treatment except that
addition of either the primary antibody or the secondary anti-
body was omitted and an equivalent volume of PBS was added
instead. The slides were imaged using a Nikon Eclipse TE2000-U
confocal microscope.
RESULTS
RPMA ANALYSIS OF HBE CELLS INFECTED WITH YERSINIA PESTIS
In order to study host cell signaling pathways that are altered
during Yp infection, including pathways that are modulated inde-
pendently of the TTSS mechanism, we compared host response
of 16HBE14o- cells (human bronchial epithelial cells) infected
with the fully virulent strain CO92 with the response to infec-
tion with a derivative avirulent strain, CO92 (Pgm-, Pst-). Host
response to treatment with heat-inactivated CO92 or LPS was
also analyzed side by side. Untreated and uninfected cells were
also included as controls. For the avirulent strain CO92 (Pgm-,
Pst-), we found that about 5% of the bacteria were taken up by
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Table 3 | Discovery of novel hits and validation of previous findings in the context of Yp infection.
Novel proteins Functional relevance Category
Bad (S112) Apoptosis/Survival 3, 4
Bad (S136) Apoptosis/Survival 3, 4
Bad (S155) Apoptosis/Survival 1
Cl-Caspase-6 (D162) Apoptosis/Survival 2
cMyc Apoptosis/Survival, Growth 2
c-Abl (T735) Apoptosis/Survival, Growth 4
p53 Apoptosis/Survival, Autophagy Regulation, Cell cycle 2
p53 (S15) Apoptosis/Survival, Autophagy Regulation, Cell cycle 1
AMPK-α1 (S485) Apoptosis/ Survival, Autophagy Regulation, Homeostasis 1
SHIP1 (Y1020) Apoptosis/Survival, Growth 2
SHP2 (Y580) Apoptosis/Survival, Growth 1, 2
Chk-1 (S345) Apoptosis/Survival, Growth, Cell cycle 1
iNOS Immune response 3, 4
Histone H3, Di-methyl (Lys9) Chromatin structure 1, 2
Ras-GRF1 (S916) Cytoskeleton modulation 1
Reported proteins Functional relevance Reference(s)
REPORTED FOR YERSINIA PESTIS
Cl-Caspase-3 (D175) Caspase activity low with Yp Kim YopJ
Pla degrades FasL, which decreases Caspase-3 activation
YopK contributes to Caspase-3 cleavage
Zheng et al., 2012
Caulfield et al., 2014
Peters et al., 2013
Cl-Caspase-7 (D198) Caspase-7 activity low with Yp Kim YopJ
Pla degrades FasL, which decreases Caspase-7 activation
Zheng et al., 2012
Caulfield et al., 2014
Cl-PARP (D214) Cleaved-PARP indicates caspase pathway activation by Yp Zheng et al., 2012
REPORTED FOR OTHER YERSINIA SPECIES
Akt (S473), Akt (S308) Y. enterocolitica YopH inactivates Akt pathway Sauvonnet et al., 2002
Cl-Caspase-9 (D330) Cl-Caspase-9 (D315) Y. enterocolitica YopP activates Caspase-9 through Bid Denecker et al., 2001
CREB (S133) YopJ of Y. pseudotuberculosis can block CREB activation Meijer et al., 2000
GSK-3α (S21) Y. enterocolitica YopH modulates PI3K/Akt/GSK-3α pathway Sauvonnet et al., 2002
P90RSK (S380) Y. enterocolitica YopM induces sustained RSK activation Hentschke et al., 2010
REPORTED USING RECOMBINANT PROTEINS OR TRANSFECTED CELLS
Akt (S473), Akt(S308) Akt is involved in Y. pseudotuberculosis entry into host cells Uliczka et al., 2009
ERK 1/2 (T202/Y204) rF1 induces phosphorylation of ERK1/2 in macrophages
rYopB and rLcrV inhibit expression of phospho-ERK 1/2
Sharma et al., 2005b
Sodhi et al., 2004
PLC-γ-1 (Y783) PLC-γ-1 plays a role in Y. pseudotuberculosis cell entry Uliczka et al., 2009
Gab1 (Y627) Transfected YopH of Yp associates with Gab1 De la Puerta et al., 2009
SAPK/JNK JNK plays a role in rF1 induced activation of macrophages Sharma et al., 2005a
Novel protein hits discovered through the RPMA analysis and protein hits that have been previously implicated for relevance to the process of Yersinia infections are
listed. For the novel hits, the affected pathways in which they are known to be involved are indicated; the bold type highlights those pathways that are implicated
by the specific RPMA changes observed for these proteins during Yp infection. Previously reported proteins are separated based on whether the studies had been
performed in the context of Yp infection or infection with other Yersinia species, as well as studies that were based on treatment with recombinant Yp proteins or
cell transfections.
the 16HBE14o- cells during infection at MOI of 10. While a 4-
fold increase in the number of intracellular bacteria was observed
by 8 h post infection, the bacteria stopped growing after this time
and the same number of intracellular bacteria as the 8 h time
point was observed at 24 h post infection. For our RPMA analy-
sis, 30min, 1, 4, and 8 h post infection times were analyzed using
111 different host-specific pre-validated antibodies, in order to
quantify changes in protein phosphorylation levels or total pro-
tein levels (Table S1). The antibodies were selected to allow a wide
range functional analysis of host cellular pathways (Table S1),
and also included those that are known or suggested from previ-
ous studies to be affected during Yp infection, such as apoptosis,
cytoskeletal modulation, inflammation, immune response, and
autophagy.
The heat map in Figure 1 presents an unsupervised hierarchi-
cal 2-way clustering analysis of the RPMA data. According to this
analysis, similar host response profiles were observed between the
virulent and avirulent Yp strains, particularly at the later time
points (4 and 8 h post infection). On the other hand, samples
treated with heat-killed bacteria group with the untreated and
www.frontiersin.org February 2015 | Volume 6 | Article 50 | 5
Alem et al. Host response to Yersinia pestis
FIGURE 1 | Heat map of RPMA results. The Heat map shows
unsupervised hierarchical 2-way clustering analysis of all the samples
analyzed by RPMA. Rows represent the different samples used in the
RPMA analysis and the columns represent the different antibodies that
were tested. Relative signal intensities were assigned based on
comparison with the lowest signals on the arrays. Red color depicts
higher signal values and green color depicts lower signal values; color
intensity indicates the strength of signal.
LPS-treated controls group. While the host response profile to
live bacteria appears distinct from that of the control samples as
a whole, there is no discernable clustering of the proteins accord-
ing to functional categories or pathways with regard to treatment
with live bacteria versus the control samples.
IDENTIFICATION AND CATEGORIZATION OF PROTEINS WITH
SIGNIFICANT FOLD CHANGE
To identify changes in the protein expression levels or specific pro-
tein phosphorylation during Yp infection, relative fold changes
were calculated by normalizing the samples with respect to the
uninfected and untreated control samples for each time point.
The thresholds for significant fold change was set to 1.5-fold
or higher for phosphorylation events and 2-fold or higher for
total protein levels. The identified hits were then categorized into
4 distinct categories that allow distinguishing the changes that
are unique to infection with the fully virulent strain (CO92)
from those that occur in response to infection with the aviru-
lent strain, or significant changes that are observed during LPS
and heat-killed bacterial treatments (Table 1). This categoriza-
tion also highlights significant changes that are not unique to any
particular treatment and are observed during two or more of the
treatment conditions that we have tested.
Category 1 proteins are those that showed a significant change
only in response to fully virulent Yp CO92 strain. Categories 2a
and 2b are those that showed a significant change in response
to either the attenuated strain alone or in response to both the
attenuated and virulent strains, respectively. Category 3 proteins
designate those that showed a significant change in response
to the heat-inactivated CO92, and are subdivided into subcate-
gories 3a, 3b, and 3c. Category 3a refers to significant changes
in response to the heat inactivated treatment alone; categories 3b
refers to significant changes in response to both the heat inacti-
vated bacteria and the avirulent strain, and category 3c designates
significant responses that are observed for heat inactivated bac-
teria, the avirulent strain, and the virulent strain. Category 4
proteins signify those that showed significant fold changes in
response to LPS treatment, and are subdivided into subcategories
4a, 4b, 4c, and 4d. Category 4a refers to significant changes in
response to LPS treatment only. Category 4b refers to signifi-
cant changes in response to both the LPS treatment and infection
with the virulent strain. Category 4c designates those proteins
that showed significant fold change in response to LPS treatment,
treatment with the heat-inactivated bacteria, and infection with
the virulent strain. Category 4d designates proteins that showed
significant change in response to all four treatments conditions.
Of all the proteins analyzed by RPMA, 25 proteins were identi-
fied to exhibit significant fold changes, as defined by the assigned
threshold values for significance (Table 2).
Category 1 consists of 6 proteins that show significant
phosphorylation increases (AKT-S473 and-T308, AMPKa1-S485,
CHK1-S345, Ras-GRF1-S916, p53-S15, and BAD-S155). These
proteins are known to be involved in multiple intracellular
signaling pathways, and based on their established roles the
consequences of the observed RPMA changes suggest apop-
totic/survival and/or autophagy-related functional outcomes
(Table 2). Therefore, the RPMA results show that during the early
phases of Yp infection the apoptosis/survival pathways andmech-
anisms involved in negative regulation of autophagy are among
the very key signaling mechanisms that become engaged. Within
category 1, with the exception of Ras-GRF1(S916) that was altered
within the first hour post infection, the remainder of the proteins
showed significant changes later, at 8 h post infection.
Category 2 contains 15 proteins, 9 of which show signifi-
cant increases in either protein levels or phosphorylation post
infection (Histone H3 Di-methyl (Lys9), SAPK/JNK, Cleaved cas-
pase 3-D175, Cleaved caspase 6-D162, Cleaved caspase 7-D198,
Cleaved caspase 9-D330 and -D315, p53, Cleaved PARP-D214,
and c-Myc) and 6 of which show a significant decrease in
phosphorylation (SHP2-Y580, Gab1-Y627, ERK 1/2-T202/Y204,
PLC-γ-1-Y783, p38-T180/Y182, and SHIP1-Y1020). Except for
Histone H3 Di-methyl (Lys9), all the other proteins in this
category are known to be involved in the apoptosis/survival path-
ways and the specific phosphorylation changes shown by RPMA
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for 12 of these proteins point to an overall induction of apop-
tosis following Yp infection (Table 2). This striking observation
suggests that within category 2 (which designates changes elicited
by the avirulent Yp strain alone, or by both the avirulent and
the virulent strains) a major signaling response of the host is the
activation of cell death pathways.
The remaining 6 host proteins from the total of 25 identi-
fied hits belong to category 3 (treatment with heat-killed Yp)
and/or category 4 (LPS treatment). Because these treatment con-
ditions are devoid of TTSS function, the host protein changes
observed in response to these treatments cannot be caused by
TTSS-dependent mechanisms, but clearly extensive future studies
are required to identify the mechanisms that cause the observed
host changes during these treatment conditions. The live Yp
strains also elicited significant changes for some of these pro-
teins (listed for subcategories 3b, 3c, and 4b, 4c, and 4d). The
6 proteins, iNOS, cAbl-T735, CREB-S133, BAD-S112 and -S136,
GSK-3α-S21, and P90RSK-S80, all show significant fold increase,
with some as early as 30min post infection. For category 3, the
increased phosphorylations of the BAD protein at S112 and S136
residues lead to an inhibition of its apoptotic functions and there-
fore are predicted to promote cell survival. Furthermore, the
observed significant increases in iNOS levels, activation of CREB
by phosphorylation at S133, and inhibition of GSK-3α by phos-
phorylation at S21, are all predicted to lead to survival outcomes
based on the known functions of these proteins (Park et al., 2005;
Song et al., 2005; Kotliarova et al., 2008). Therefore, our RPMA
results point to a coordinated early induction of survival dur-
ing Yp infection of lung epithelial cells that can occur through
TTSS-independent mechanisms.
VALIDATION OF RPMA RESULTS BY WESTERN BLOTS
Even though RPMA antibodies have already been pre-validated
and reported in previous RPMA publications (Popova et al., 2010;
Wilson et al., 2010; Younossi et al., 2011; Sereni et al., 2013), we
nevertheless performed another tier of validation of our RPMA
results by Western blot analysis of selected hits, testing both the
same sample set that was used for the RPMA analysis and a bio-
logical replicate sample set. Multiple RPMA hits were validated
by Western blot and two representative examples are presented in
Figure 2, for cleaved PARP (D214) and p53 (S15) proteins. Our
Western analysis confirms the RPMA findings of an increase in
PARP (D214) levels and activation of p53 by increased phospho-
rylation at S15 residue during Yp infection (Figures 2A,D). For
different treatment conditions, fold changes in protein levels or
phosphorylation levels were measured by comparing the band
intensities to untreated controls, and the comparisons between
the RPMA and Western fold changes for Cleaved PARP (D214)
and p53 (S15) are presented (Figures 2B,E). Two-way scatter plot
analysis shows strong positive correlation between the western
blot and RPMA results, with a R2 value of 0.9 for cleaved PARP
(D214) and a R2 value of 0.98 for p53 (S15) (Figures 2C,F).
DISCOVERY OF NOVEL PROTEINS AND CONFIRMATION OF PREVIOUS
FINDINGS WITHIN THE CONTEXT OF Y. PESTIS INFECTION
Our RPMA analysis of the human lung epithelial cells yielded 25
proteins that displayed significant changes in either site-specific
phosphorylation or total protein levels in response to Yp infec-
tions; a complete list of these proteins as well as the pathways
engaged by the novel hits are shown in Table 3. After a com-
prehensive literature search, 12 of the 25 hits were identified to
be novel findings, and have not been previously reported for
Yp infection. Our study also led to the identification of several
hits that have been previously reported, although the major-
ity of them have been reported either in the context of infec-
tion with other Yersinia species or within the context of using
recombinant proteins and transfections with specific Yp com-
ponents (Table 3). Thus, our identification of several previously
reported changes not only provides an important level of vali-
dation for our RPMA findings but also places a number of the
previous reports within the more relevant context of whole infec-
tion with Yp, which we have performed using a relevant model
cell type and under both fully virulent and avirulent infection
conditions.
Two of the main pathways that are highlighted by our novel
hits are the autophagy and survival-related pathways. In addition,
cell cycle and growth regulation, and regulation of chromatin
structure, are implicated. The identification of these novel hits
by RPMA helps to fill in the current gap of knowledge with
regard to the overall signaling network changes that occur dur-
ing early response to infection with Yp. For instance, as discussed
in the next section, our discovery of specific changes in several
proteins that regulate autophagy, together with initial mechanis-
tic results, leads to a model of negative regulation of autophagy
during early response of human lung epithelial cells to Yp
infection.
EVIDENCE FOR NEGATIVE REGULATION OF AUTOPHAGY
Several identified hits are proteins that are known to regulate
the autophagy process; pAKT (S473 and T308), AMPKalpha-1
(S485), and p53 (S15). Based on our RPMA analysis, the AKT
kinase is activated during infection with Yp through phospho-
rylation of its S473 residue whereas AMPK activity is lowered
through phosphorylation of its S485 residue, which is known to
lead to AMPK inactivation (Ning et al., 2011). Because activated
AKT is an inhibitor of autophagy whereas activated AMPK is an
inducer, these results suggest that autophagy is down-regulated
during the first hours post Yp infection. Our results also show
that the levels of p53, another known regulator of autophagy,
are significantly increased during Yp infection. Because studies
have shown that cytoplasmic localization of p53 down-regulates
autophagy (Liang and Clarke, 2001; Tasdemir et al., 2008b), we
analyzed the nuclear versus cytoplasmic localization of p53 post
Yp infection. Confocal microscopy analysis showed that while
prior to infection p53 shows nuclear localization, subsequent to
Yp infection activated p53 (S15) shows significantly increased
localization in the cytoplasm compared to uninfected controls
(Figure 3A). Specifically, 91% of infected cells examined showed a
clear presence of p53 in the cytoplasm, compared to only 15% for
the uninfected cells (Figure 3B), consistent with a negative regu-
lation of autophagy. We also analyzed the LC3 conversion from
LC3-I to LC3-II during Yp infection. Conversion from LC3-I to
LC3-II occurs through conjugation of phosphatidylethanolamine
(PE) to LC3-I and is a marker for induction of autophagy (Tanida
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FIGURE 2 | Western blot validation of RPMA results. (A,D) Western blot
analysis of human bronchial epithelial (HBE) cells for control condition
(uninfected and untreated), treatment with heat-killed Yp CO92 (HK-CO92)
or with LPS, and infection with Yp CO92 or Yp CO92 (Pgm-, Pst-). The
blot in (A) was probed with the same antibody that was used for the
RPMA analysis of cleaved PARP (D214), and the blot in (D) was probed
with the same antibody against p53 (S15) that was used for RPMA
analysis. Actin levels were also probed for all samples to serve as loading
control and allow normalization of the signals for measuring fold changes
relative to the control condition. (B,E) Bar graphs showing protein level
fold changes of cleaved-PARP (D214) in (B), and phosphorylation fold
changes of p53 (S15) in (E), for both the RPMA and Western blot analyses
of the treatment conditions. For comparison purposes, the value for the
control condition (uninfected and untreated) was set at 1. (C,F) Two-way
scatter plot showing positive correlation between the RPMA results and
the Western blot results for Cleaved-PARP (D214) and p53 (S15).
et al., 2008). This conjugation leads to the recruitment of LC3-
II to the phagosomal membrane, and as autophagy is induced
the ratio of LC3-II to LC3-I increases. Our data shows that after
infection with Yp the ratio of LC3-II/LC3-I decreases approxi-
mately 2-fold in comparison to the uninfected/untreated condi-
tion and also the LPS treatment condition (Figure 4), indicating
an inhibition of autophagy. Together, the LC3 and p53 results are
consistent with a model of negative regulation of autophagy fol-
lowing Yp infection and suggest a coordinated down-regulation
through activation of AKT, inhibition of AMPK, and cytoplasmic
localization of p53 (Figure 5).
DISCUSSION
We took advantage of the high throughput assay format and high
sensitivity and reliability of the RPMA platform to quantitatively
profile the host response to Y. pestis infection, particularly the
signaling pathways that become modulated. Because the RPMA
platform is amenable to simultaneous analysis of numerous
pathways, it affords the possibility of measuring the overall signal-
ing network changes that occur in the cell. For measuring changes
in phosphorylation states or total protein levels, we probed with
a total of 111 antibodies that span multiple functional categories
relevant to infection processes, including apoptosis and survival,
autophagy, cell cycle regulation and cellular growth, cytoskele-
ton modulation and cellular migration, immune response, and
chromatin modulation. One of the cell types that we analyzed
was the human bronchial epithelial cell line 16HBE14o-, which
has been demonstrated to serve as a model system of the air-
ways (Forbes et al., 2003). We used both a fully virulent strain of
Yp, CO92, and a derivative avirulent strain for the infections and
also profiled changes that can be elicited in a TTSS-independent
manner.
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FIGURE 3 | p53 localization in the cytoplasm of Yp-infected cells. (A)
Confocal microscopy image of HeLa cells for analysis of p53 localization. Top
panel shows cells treatedwithDoxorubicin at 1μMfor 1 h at 37◦C to induce p53
expression and serve as positive control. Middle panel shows uninfected cells
and bottom panel shows cells infectedwith Yp CO92 (Pgm-, Pst-) for 8 h. Green
fluorescence (left column) indicates activated p53 signal, obtained by probing
with p53 (S150) antibody, and blue signal (middle column) corresponds to DAPI
nuclear stain. The right column shows superimpositions of the two signals.
White arrows show p53 localization in the cytoplasm of the infected cells
compared to uninfected and Doxorubicin-treated cells. (B) For each treatment
condition, cells were scored for cytoplasmic or nuclear localization of p53 (S15)
and percentages of cells showing cytoplasmic signal were calculated.
IMPLICATION OF AUTOPHAGY, CELL CYCLE AND GROWTH, AND
SURVIVAL-RELATED PATHWAYS
Compared to the control condition (untreated and uninfected
cells), a total of 25 proteins in 16HBE14o- cells showed sig-
nificant fold change in response to the treatment conditions.
Survival-related pathways, and pathways involved in regulation
of autophagy or cell cycle and growth, are strongly highlighted
by the RPMA results. Interestingly, the functional consequences
of the RPMA changes observed for category 1 hits, which repre-
sent responses observed only for infection with the virulent Yp
strain, point to an overall activation of survival functions. Thus,
activated AKT (S743), phosphorylated Ras-GRF1 (S916) (acti-
vator of Ras), and phosphorylated BAD (S155), are all involved
in cell survival pathways (Datta et al., 1997; Brunet et al., 1999;
Downward, 2004; Jeon et al., 2012). In addition, the increased lev-
els of active CHK-1 (S345) (DNA damage cell cycle checkpoint)
also points toward activation of survival pathways (Liou et al.,
2014; Sarmento et al., 2014; Wang et al., 2014).
Category 2 proteins also strongly point to regulation of
survival-related pathways, although unlike category 1 proteins the
observed RPMA changes highlight more the activation of cell
death pathways. In addition, inhibition of cell growth and pro-
liferation is suggested by some of the observed changes. Thus, the
specific modulations observed for 12 of the 15 proteins in this
category suggest activation of apoptotic functions (Evan et al.,
1992; Packham and Cleveland, 1995; Verheij et al., 1996; Hakem
et al., 1998; Janicke, 1998; Boulares et al., 1999; Porter and Jänicke,
1999; Ruiter et al., 1999; Allsopp et al., 2000; Slee et al., 2001;
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FIGURE 4 | Decreased conversion of LC3B-I to LC3B-II during Yp
infection. (A) LC3-B Western blot analysis of total cell extracts obtained
from HBE cells at 8 h post infection with CO92, or post treatment with LPS,
compared to the uninfected and untreated control. The results for two sets
of biological replicates are shown. Actin levels were also probed for all
samples to serve as loading control and allow normalization of the signals.
(B) Bar graph showing LC3II/LC3I ratios for all samples based on the
densitometry analysis for the LC3I and LC3II protein bands.
Marsden et al., 2002; Amaral et al., 2010). From this group of pro-
teins, ERK (T202/Y204), Gab1 (Y627), SHP2 (Y580), and SHIP1
(Y1020) have also been implicated for cell growth (Hakak et al.,
2000; Araki et al., 2003; Ivins Zito et al., 2004; Mattoon et al.,
2004; Gloire et al., 2006; Lu and Xu, 2006; Mood et al., 2006;
Balmanno and Cook, 2009; Eulenfeld and Schaper, 2009). Since
all of these 4 proteins show down-regulation in response to Yp
infection, these results also provide evidence for a potential down-
regulation of cell growth as part of the host response to Yp. Since
both categories 1 and 2 profile significant host responses under
functional TTSS conditions, the observed changes may be related
to the functions of the Yop effector proteins although clearly fur-
ther mechanistic studies are needed to address this question. In
addition, it remains to be investigated which of the host pathway
changes that we have observed by our RPMA analysis reflect Yp
manipulation of the host machinery and which are reflections of
direct host response.
Treatments with heat-killed CO92 strain and with LPS allowed
profiling host responses that can occur independently of the TTSS
machinery. Similar to the findings for category 1 and category
2, changes observed in response to treatment with heat killed
Yp or LPS suggest activation of survival-related pathways. For
example, BAD (Bcl-2 Associated Death) is a protein that induces
apoptosis by blocking BAX from binding to Bcl-2 or Bcl-XL,
and allows cytochrome C release from mitochondria to acti-
vate the intrinsic death pathway. Phosphorylation of the BAD
protein at Ser 136, Ser 112, or Ser 155, which are observed in
our RPMA analysis, has been shown to inactivate BAD, and
therefore promote cell survival (Datta et al., 1997; Peso, 1997;
Brunet et al., 1999). Similarly, the observed increased levels of
activated CREB (S133) is known to result in increased cell pro-
liferation and survival (Shaywitz and Greenberg, 1999; Mayr
and Montminy, 2001). GSK-3α, a serine-threonine kinase, which
influences multiple downstream pathways ranging from cell sur-
vival/apoptosis to growth and immune response (Ohteki, 2000;
Downward, 2004; Tseng et al., 2006; Kotliarova et al., 2008),
can also be modulated through TTSS-independent mechanisms.
Thus, in response to heat-killed Yp treatment, GSK-3α shows
increased phosphorylation at S21 residue during early post infec-
tion times (1 and 4 h post infection), which is known to inactivate
GSK-3α (Kotliarova et al., 2008). Consistent with our interpreta-
tions for the observed changes for the BAD and CREB proteins,
the inactivation of GSK-3α may also be pointing to promotion of
survival.
MODEL FOR NEGATIVE REGULATION OF THE AUTOPHAGY PATHWAY
Several of our identified hits are known to modulate the
autophagy process. Autophagy is a cellular mechanism that can
be utilized by the host to eliminate invading pathogens but it
can also be manipulated by the pathogen to survive and repli-
cate (Owen et al., 2014). Yersinia pestis has previously been shown
to reside in autophagosomes of mouse macrophages in order to
evade host immune responses (Pujol et al., 2009). In our study,
we observe that multiple proteins that are known to modulate
the autophagy pathway are altered in infected cells; pAKT (S743
and T380), AMPKα-1 (S485), and p53 (S15) all showed increased
levels at 8 h post infection. In active form, AMPK is a known
inducer of autophagy through its activation of ULK1 as well as
its role in blocking inhibition of autophagy by mTOR (Xu et al.,
2014). Activated AKT (phosphorylated at S473) can phosphory-
late AMPK at its S485 residue, leading to AMPK inactivation and
therefore inhibition of autophagy (Ning et al., 2011). In addi-
tion, AKT directly blocks activation of TSC2 (an inhibitor of
mTOR and inducer of autophagy) to provide further regulation
of the autophagy process (Inoki et al., 2002; Cai et al., 2006).
The p53 protein is another RPMA hit that has also been shown
to play a role in autophagy. Cytoplasmic p53 has been shown
to repress autophagy (O’Brate and Giannakakou, 2003; Mariño
et al., 2014) whereas nuclear p53 induces autophagy through
transactivation of genes that suppress mTOR (Tasdemir et al.,
2008a). Together, our RPMA results (AKT and p53 activation,
and AMPKα-1 inactivation), along with our demonstration of
the cytoplasmic localization of p53 and reduced LC3-I to LC3-II
conversion during Yp infection, provide evidence of negative reg-
ulation of autophagy as part of the host response to Yp (Figure 5).
It is of significance that the RPMA changes are mostly observed
in response to the virulent Yp strain, and therefore negative reg-
ulation of autophagy may represent an important mechanism
in determination or regulation of virulence. Further mechanis-
tic studies are required to strengthen our autophagy model and to
investigate whether it plays a role in regulation of Yp virulence, in
particular given the role of autophagy in bacterially infected cells
(Yuk et al., 2012) and the reported findings that intracellular Yp
bacteria residing in autophagosomes can avoid xenophagy (Pujol
et al., 2009).
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FIGURE 5 | Proposed model of negative regulation of autophagy during
Yp infection. Pathway map for regulation of the autophagy process highlights
proteins that were identified by the RPMA analysis (Yellow star). Red lines
depict inhibitor signals and green lines depict activation. The RPMA results
demonstrate activation of AKT and p53, and inhibition of AMPKα-1, during Yp
infection. In addition, immunofluorescence data (Figure 3) shows a dramatic
increase in cytoplasmic localization of p53 protein during Yp infection, and also
the LC3-I to LC3-II conversion is significantly reduced (Figure 4). These
findings together suggest coordinate negative regulation of autophagy in
human bronchial epithelial cells following infection with Yp.
DISCOVERY OF NOVEL HITS AND VALIDATION OF PREVIOUS STUDIES
IN THE CONTEXT OF Yp INFECTION
Our RPMA analysis led to the identification of 12 novel hits
with respect to Yp infection. Consistent with the reported impor-
tance of autophagy and apoptosis/survival pathways during Yp
infection (Pujol et al., 2009; Ke et al., 2013; Peters et al., 2013;
Caulfield et al., 2014), many of the novel hits implicate these
pathways. Furthermore, the cell cycle and growth control path-
ways are implicated through modulation of proteins such as
Chk-1 (S345), c-Myc, SHIP1 (Y1020), or SHP2 (Y580) given the
reported functions of these proteins (Schmidt, 1999; Liu et al.,
2000; Gloire et al., 2006; Yang et al., 2006; Niida et al., 2007;
Tsang et al., 2012). A level of validation of our RPMA results
comes from identification of several hits that have been previ-
ously reported to be relevant (Table 3). For instance, the RPMA
hits Gab1, Gab2, and Lck have been shown to be targeted by
YopH in order to regulate the host immune response (De la Puerta
et al., 2009). Or, extending previous findings for infection with
Y. pseudotuberculosis (Uliczka et al., 2009), our RPMA results
show that the AKT kinase is also activated during infection with
Yp. However, the majority of the previous reports related to our
RPMA hits have been either in relation to infection with other
Yersinia species or within the context of using recombinant pro-
teins and transfections with specific Yp components (Table 3).
Therefore, beyond providing a level of validation, our identifica-
tion of several reported changes also places a number of the previ-
ous findings within the more relevant context of whole infection
with Yp.
With continuing significant concern over the rising level of
antibiotic resistance for many bacterial infections, focusing on
development of host-based therapies founded on an understand-
ing of the host response mechanisms provides a viable alterna-
tive for devising effective countermeasures. In addition, a better
understanding of the host response networks will allow advances
in development of much needed vaccines and early diagnostic
measures. The type of high throughput host protein analysis that
is afforded by RPMA and has been presented here provides a
unique opportunity to measure protein network changes that
occur across the host cell in response to infection. The RPMA
results presented here should provide a strong foundation for fur-
ther mechanistic studies of Yp infection, and help pave the way
for devising novel effective countermeasures for treatment and
prevention of plague.
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